Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 27 March, 2020

Morgan Stanley Cap

Rule 38.5 - Replacement of ABBVIE INC

RNS Number : 9312H
Morgan Stanley Capital Services LLC
27 March 2020
 

AMENDMENT Section (2b)

 

  FORM 38.5

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)

 

DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS

 

1.  KEY INFORMATION

 Name of exempt market-maker

  Morgan Stanley Capital Services LLC

 Company dealt in

  ABBVIE INC.

 Class of relevant security to which the dealings being disclosed relate (Note 1)

  US$0.01 COMMON STOCK

 Date of dealing

  16 MARCH 2020

 

 

2.  DEALINGS  (Note 2)

 

(a)  Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

   96,390

 81.9900 USD

 73.6700 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

   57,070

 81.7800 USD

 73.6500 USD

 

 

(b)  Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

  (Note 4)

 Number of relevant securities

  (Note 5)

 Price per unit

 CFD

 LONG

 2,783

 73.8382 USD

 CFD

 LONG

 1,290

 74.1408 USD

 CFD

 LONG

 6,188

 74.2700 USD

 CFD

 LONG

 672

 74.2700 USD

 CFD

 LONG

 45

 74.6051 USD

 CFD

 LONG

 100

 76.3401 USD

 CFD

 LONG

 1,299

 76.3464 USD

 CFD

 LONG

 433

 76.9850 USD

 CFD

 LONG

 100

 77.0878 USD

 CFD

 LONG

 600

 77.0878 USD

 CFD

 LONG

 2,200

 77.0878 USD

 CFD

 LONG

 1,200

 77.0878 USD

 CFD

 LONG

 700

 77.0878 USD

 CFD

 LONG

 7,361

 77.1548 USD

 CFD

 LONG

 40

 77.1600 USD

 CFD

 LONG

 197

 77.8965 USD

 CFD

 LONG

 8,463

 77.8965 USD

 CFD

 LONG

 79

 78.7145 USD

 CFD

 LONG

 521

 78.7145 USD

 CFD

 LONG

 3

 78.8600 USD

 CFD

 LONG

 197

 79.4979 USD

 CFD

 LONG

 8,463

 79.4979 USD

 CFD

 LONG

 881

 80.3601 USD

 CFD

 LONG

 400

 81.7491 USD

 CFD

 SHORT

 65

 74.2700 USD

 CFD

 SHORT

 20

 74.2700 USD

 CFD

 SHORT

 3,421

 74.8673 USD

 CFD

 SHORT

 8,971

 75.5343 USD

 CFD

 SHORT

 47,815

 76.9453 USD

 CFD

 SHORT

 4,700

 77.0201 USD

 CFD

 SHORT

 35

 77.3400 USD

 CFD

 SHORT

 3,681

 77.5248 USD

 CFD

 SHORT

 5

 80.1300 USD

 CFD

 SHORT

 9,500

 80.3499 USD

 CFD

 SHORT

 1,500

 80.6786 USD

 

 

(c)  Options transactions in respect of existing relevant securities

 

i)  Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 N/A

 N/A

 N/A 

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

 27 MARCH 2020

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ABBVIE INC.

Nature of connection (Note 6)

Advisory

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEQDLFLBXLLBBX

a d v e r t i s e m e n t